Birth Cohort Study of China Medical University (NCT03561766) | Clinical Trial Compass
RecruitingNot Applicable
Birth Cohort Study of China Medical University
China1,000 participantsStarted 2018-06-15
Plain-language summary
The CMUBCS is a birth cohort study located in Shenyang, China. Its initial aim is to facilitate research on understanding the interplay between genes and environmental factors on disease etiology. Data are collected regarding environmental factors, family and lifestyle, clinical experimental outcomes and imaging results of pregnant women and children from birth to 18 years old. Biological samples including blood and tissue samples are also collected from the children and their parents.
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Pregnant women, \<13 gestational weeks
. Permanent residents or families intended to remain in Shenyang and surrounding areas
. Pregnant women who are planned to be examined and delivered in Shengjing Hospital.
Exclusion criteria
. Pregnant women who refuse to take part in the study
. Pregnant women have diseases that might affect the results of researches, including neuropsychiatric disorders.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change of biometric parameter in centimeter of fetuses at the thirteenth week of gestational age
Timeframe: At every week from the thirteenth week of gestational age to delivery of babies
2
Weight in kilogram of neonate
Timeframe: At birth of neonate
3
Gene expression of husbands of pregnancy women
Timeframe: At 13 weeks of gestational age
4
Change of gene expression of pregnancy women
Timeframe: At 13, 26 and 34 weeks of gestational age